We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK TO FDA: BLOCK GENERIC FLONASE UNTIL FINAL GUIDANCE IS ISSUED
GSK TO FDA: BLOCK GENERIC FLONASE UNTIL FINAL GUIDANCE IS ISSUED
June 4, 2004
A citizen petition filed last week with the FDA is delaying final approval of a generic version of GlaxoSmithKline’s (GSK’s) profitable allergy nasal spray drug Flonase, generic drug sources said.